Bibliography
- Niemeier V, Kupfer J, Demmelbauer-Ebner M. Coping with acne vulgaris. Evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology 1998;196:108-15
- Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne? Exp Dermatol 2005;14:143-52
- Gollnick H, Schramm M. Topical drug treatment in acne. Dermatology 1998;196:119-25
- Rietschel RL, Duncan SH. Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Int J Dermatol 1983;22:41-3
- Clindamycin/tretinoin: clindamycin phosphate/tretinoin gel. Drugs R&D 2005;6:231-4
- Rao S, Malik MA, Wilder L, Mott T. Clinical inquiries. What is the best treatment for mild to moderate acne? J Fam Pract 2006;55:994-6
- Wolfe JE Jr. Potential anti-inflammatory effects of topical retinoids and retinoid analogues. Adv Ther 2002;19:109-18
- Shalita A. The integral role of topical and oral retinoids in the early treatment of acne. J Eur Acad Dermatol Venereol 2001;15:43-9
- Papakonstantinou E, Aletras AJ, Glass E, et al. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol 2005;125:673-84
- Oeff MK, Seltmann H, Hiroi N, et al. Differential regulation of toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology 2006;213:266
- Wauben-Penris PJ, Cerneus DP, Van Den Hoven WE, et al. Immunomodulatory effects of tretinoin in combination with clindamycin. J Eur Acad Dermatol Venereol 1998;11:S2-7
- Liu PT, Krutzik SR, Kim J, Modlin RL. Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J Immunol 2005;174:2467-70
- Kim J. Review of the innate immune response in acne vulgaris: activation of toll-like receptor-2 in acne triggers inflammatory cytokine responses. Dermatology 2005;211:193-8
- Tan HH. Topical antibacterial treatments for acne vulgaris: comparative review and guide to selection. Am J Clin Dermatol 2004;5:79-84
- Toyoda M, Morohashi M. An overview of topical antibiotics for acne treatment. Dermatology 1998;196:130-4
- Van Hoogdalem EJ, Baven TL, Spiegel-Melsen I, Terpstra IJ. Transdermal absorption of clindamycin and tretinoin from topically applied anti-acne formulations in man. Biopharm Drug Dispos 1998;19:563-9
- Leyden JJ, Krochmal L, Yaroshinsky A. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris. J Am Acad Dermatol 2006;54:73-81
- Feingold DS, Chen WC, Chou DL, Chang TW. Induction of colitis in hamsters by topical application of antibiotics. Arch Dermatol 1979;115:580-1
- Sackett D, Strauss S, Richardson W, et al. Evidence-based medicine: how to practice and teach EBM. London: Churchill Livingstone; 2001. p. 169-82
- Zouboulis CC, Derumeaux L, Decroix J, et al. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris. Br J Dermatol 2000;143:498-505
- Richter JR, Förström LR, Kiistala UO, Jung EG. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne. J Eur Acad Dermatol Venereol 1998;11:227-33
- Cambazard F. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris. J Eur Acad Dermatol Venereol 1998;11:S20-7
- Schlessinger J, Menter A, Gold M, et al. Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. J Drugs Dermatol 2007;6:607-15
- Bowman S, Gold M, Nasir A, Vamvakias G. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study. J Drugs Dermatol 2005;4:611-8
- Taylor SC. Utilizing combination therapy for ethnic skin. Cutis 2007;80:15-20
- Lipson AH, Collins F, Webster WS. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet 1993;341:1352-3
- Camera G, Pregliasco P. Ear malformation in baby born to mother using tretinoin cream. Lancet 1992;339:687
- Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 2003;4:473-92
- Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet 1993;341:1181-2
- Loureiro KD, Kao KK, Jones KL, et al. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A 2005;136:117-21
- Buchan P, Eckoff C, Caron D, et al. Repeated topical administration of all-trans-retinoic acid and plasma levels of retinoic acids in humans. J Am Acad Dermatol 1994;30:428-34
- Krautheim A, Gollnick HPM. Acne: topical treatment. Clin Dermatol 2004;5:398-407